Related Experiment Video
Updated: Aug 12, 2025
08:21
High-Dimensionality Flow Cytometry for Immune Function Analysis of Dissected Implant Tissues
Published on: September 15, 2021
2.3K
Biomaterials-Mediated Engineering of the Immune System
Coralie Backlund1, Sasan Jalili-Firoozinezhad1, Byungji Kim1
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA;
Annual Review of Immunology
|January 25, 2023
Summary
Biomaterials precisely control immune system modulation for safer vaccines and therapies. This approach enhances immune engineering, improving therapeutic development while minimizing side effects.
Area of Science:
- Immunology
- Biomaterials Science
- Therapeutic Development
Background:
- Immune system modulation is key for treating diseases and developing vaccines.
- Current immunotherapies lack precision, leading to potential toxicity and improper immune response.
- Biomaterials offer a solution for controlled delivery of immune stimulatory cues.
Purpose of the Study:
- To discuss how biomaterials are used to enhance immune modulation.
- To review evidence of biomaterials-mediated immune engineering in preclinical and clinical studies.
- To highlight challenges in translating these biomaterial technologies to clinical practice.
Main Methods:
- Review of fundamental concepts in biomaterials for immune modulation.
- Analysis of preclinical and clinical evidence for biomaterials-mediated immune engineering.
- Focus on immunological mechanisms and in vivo modulation.
Main Results:
- Biomaterials enable precise control over the location, dose, and timing of vaccines and immunotherapies.
- Biomaterials-mediated immune engineering shows significant impact on therapeutic development.
- Evidence supports the potential of biomaterials to enhance immune responses safely and effectively.
Conclusions:
- Biomaterials are crucial for advancing precision immunotherapy and vaccine development.
- Further research and overcoming translational challenges are needed to fully realize the clinical potential of biomaterial-based immune engineering.
- Biomaterials represent a promising strategy for safer and more effective immune modulation therapies.
